OA11997A - Streptomyces avermitillis gene directing the ratioof B2:B1 avermectins. - Google Patents

Streptomyces avermitillis gene directing the ratioof B2:B1 avermectins. Download PDF

Info

Publication number
OA11997A
OA11997A OA1200200024A OA1200200024A OA11997A OA 11997 A OA11997 A OA 11997A OA 1200200024 A OA1200200024 A OA 1200200024A OA 1200200024 A OA1200200024 A OA 1200200024A OA 11997 A OA11997 A OA 11997A
Authority
OA
OAPI
Prior art keywords
leu
ala
val
gly
arg
Prior art date
Application number
OA1200200024A
Other languages
English (en)
Inventor
Kim Jonelle Stutzman-Engwall
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of OA11997A publication Critical patent/OA11997A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623Avermectin; Milbemycin; Ivermectin; C-076

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
OA1200200024A 1999-08-12 2000-07-19 Streptomyces avermitillis gene directing the ratioof B2:B1 avermectins. OA11997A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/372,934 US6248579B1 (en) 1998-02-13 1999-08-12 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins

Publications (1)

Publication Number Publication Date
OA11997A true OA11997A (en) 2006-04-18

Family

ID=23470234

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200200024A OA11997A (en) 1999-08-12 2000-07-19 Streptomyces avermitillis gene directing the ratioof B2:B1 avermectins.

Country Status (37)

Country Link
US (8) US6248579B1 (de)
EP (1) EP1200605B1 (de)
JP (2) JP3688640B2 (de)
KR (1) KR100486006B1 (de)
CN (1) CN1186447C (de)
AP (2) AP2002002417A0 (de)
AR (1) AR021450A1 (de)
AT (1) ATE283363T1 (de)
AU (1) AU779756B2 (de)
BG (1) BG106478A (de)
BR (1) BR0013093A (de)
CA (1) CA2381427A1 (de)
CO (1) CO5290296A1 (de)
CZ (1) CZ2002297A3 (de)
DE (1) DE60016231T2 (de)
EA (1) EA004569B1 (de)
ES (1) ES2231214T3 (de)
GT (2) GT200000138A (de)
HK (1) HK1046536B (de)
HR (1) HRP20020131A2 (de)
HU (1) HUP0202517A2 (de)
IL (1) IL147562A0 (de)
IS (1) IS6249A (de)
MA (1) MA26811A1 (de)
MX (1) MXPA02001514A (de)
NO (1) NO20020665L (de)
OA (1) OA11997A (de)
PA (1) PA8499201A1 (de)
PE (1) PE20010697A1 (de)
PL (1) PL353770A1 (de)
PT (1) PT1200605E (de)
SK (1) SK1382002A3 (de)
TN (1) TNSN00170A1 (de)
UY (1) UY26287A1 (de)
WO (1) WO2001012822A1 (de)
YU (1) YU8402A (de)
ZA (1) ZA200201071B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0013119B8 (pt) * 1999-08-12 2021-05-25 Pah Usa 15 Llc molécula polinucleotídica isolada, vetor recombinante purificado, célula hospedeira procariótica e célula de streptomyces avermitilis mutada, método para obtenção de uma nova cepa de s. avermitilis e processo para produção de avermectinas
JP2005516987A (ja) 2002-02-05 2005-06-09 ブリストル−マイヤーズ スクイブ カンパニー N−置換された3−ヒドロキシ−4−ピリジノン化合物およびそれを含む医薬
PT1476539E (pt) 2002-02-12 2009-04-09 Pfizer Prod Inc Gene streptomyces avermitilis que dirige a proporção de avermectinas b2:b1
US7943160B2 (en) * 2002-05-09 2011-05-17 Scimetrics Limited Corp. Pest control methods
US8440609B2 (en) * 2003-01-31 2013-05-14 Gerd Wallukat Peptides against autoantibodies causing intolerance to cold and use thereof
KR100759130B1 (ko) 2005-02-12 2007-09-19 휴메드 주식회사 항 인테그린 항체 코팅스텐트 및 그의 제조방법
CN106148216B (zh) 2015-03-27 2019-06-04 浙江海正药业股份有限公司 一种链霉菌及其生产米尔贝霉素a3的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234831A (en) 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
US5525506A (en) 1987-01-23 1996-06-11 Pfizer Inc. Process for production of avermectins and cultures therefor
US5238848A (en) 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
DE3881147T2 (de) 1987-10-23 1993-09-02 Pfizer Verfahren zur herstellung von aglykonen von avermectin und sie enthaltende kulturen.
US5240850A (en) 1987-10-23 1993-08-31 Pfizer Inc. Cultures for production of avermectin aglycones
ES2079436T3 (es) 1989-03-31 1996-01-16 Merck & Co Inc Clonacion de genes de streptomyces avermitilis para biosintesis de avermectinas y procedimientos para su uso.
US5252474A (en) 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
JP2807348B2 (ja) 1993-07-30 1998-10-08 ファイザー・インコーポレーテッド ストレプトミセス・アベルミティリスからの分岐状鎖α−ケト酸デヒドロゲナーゼ複合体をコードする遺伝子
RU2120943C1 (ru) * 1993-10-05 1998-10-27 Пфайзер Инк. Производные дорамектина, способы их получения, способы лечения
FI942725L (fi) 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
CN1521180A (zh) * 1998-02-13 2004-08-18 �Ʒ� 介导除虫菌素b2:b1比例的除虫链霉菌基因

Also Published As

Publication number Publication date
HK1046536A1 (en) 2003-01-17
DE60016231T2 (de) 2005-12-08
US20050196777A1 (en) 2005-09-08
ES2231214T3 (es) 2005-05-16
AU779756B2 (en) 2005-02-10
CN1186447C (zh) 2005-01-26
AP2002002419A0 (en) 2002-03-31
NO20020665D0 (no) 2002-02-11
US7029887B2 (en) 2006-04-18
KR100486006B1 (ko) 2005-05-03
US20010016350A1 (en) 2001-08-23
HRP20020131A2 (en) 2003-12-31
AR021450A1 (es) 2002-07-17
UY26287A1 (es) 2001-03-16
HK1046536B (zh) 2005-05-13
US20030134313A1 (en) 2003-07-17
CA2381427A1 (en) 2001-02-22
JP3688640B2 (ja) 2005-08-31
EP1200605B1 (de) 2004-11-24
CO5290296A1 (es) 2003-06-27
US20030129636A1 (en) 2003-07-10
PE20010697A1 (es) 2001-07-05
GT200000138A (es) 2002-02-02
US6833263B2 (en) 2004-12-21
PT1200605E (pt) 2005-04-29
PA8499201A1 (es) 2001-12-14
AP2002002417A0 (en) 2002-03-31
EA004569B1 (ru) 2004-06-24
US6248579B1 (en) 2001-06-19
IS6249A (is) 2002-01-25
BR0013093A (pt) 2002-08-13
IL147562A0 (en) 2002-08-14
US6509159B2 (en) 2003-01-21
US6511841B2 (en) 2003-01-28
TNSN00170A1 (fr) 2005-11-10
HUP0202517A2 (hu) 2002-11-28
US20030124607A1 (en) 2003-07-03
JP2005198658A (ja) 2005-07-28
JP2003507018A (ja) 2003-02-25
CN1370239A (zh) 2002-09-18
ATE283363T1 (de) 2004-12-15
US7259241B2 (en) 2007-08-21
DE60016231D1 (de) 2004-12-30
KR20020022809A (ko) 2002-03-27
WO2001012822A1 (en) 2001-02-22
EA200200057A1 (ru) 2002-06-27
EP1200605A1 (de) 2002-05-02
SK1382002A3 (en) 2002-11-06
MA26811A1 (fr) 2004-12-20
MXPA02001514A (es) 2002-07-02
NO20020665L (no) 2002-02-11
BG106478A (bg) 2004-02-27
GT200000138CA (es) 2002-02-02
ZA200201071B (en) 2003-06-25
AU5702100A (en) 2001-03-13
CZ2002297A3 (cs) 2002-08-14
PL353770A1 (en) 2003-12-01
US20010024818A1 (en) 2001-09-27
YU8402A (sh) 2006-03-03
US20030129635A1 (en) 2003-07-10

Similar Documents

Publication Publication Date Title
US6509159B2 (en) Methods related to Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
AU752343C (en) Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
CA2380872C (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
MXPA04007777A (es) Gen de streptomyces avertmitilis que rige la relacion de avermectinas b2:b1.
AU779569B2 (en) Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
MXPA00007915A (en) I(streptomyces avermitilis) gene directing the ratio of b2:b1 avermectins